Four sessions covering: Indications for initiating insulin replacement therapy in type 2 diabetes; post-prandial hyperglycemia effect on A1C; ADA/EASD recommendation for “A1C trigger level” for treatment intensification; pharmacokinetics and place in therapy of available insulin products; strategies for individualizing insulin regimens.
Read More »